|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 2003;75:483-484
© 2003 The Society of Thoracic Surgeons
Department of Anesthesiology, Emory University Hospital, 1364 Clifton Rd, NE, Atlanta, GA 30322, USA
e-mail: jerrold_levy@emoryhealthcare.org
| The first 20% of the full text of this article appears below. |
Stroke is one of the most devastating complications following cardiac surgery. In 1995, we reported a prospective study in patients undergoing repeat coronary artery bypass graft surgery and noted that administration of full dose and half dose aprotinin significantly reduces the requirement for donor-blood transfusion. Although the study was not specifically designed to assess aprotinin and stroke risk, the decreased need for transfusion was associated with a decreased incidence of stroke [1]. Interestingly, this finding has been confirmed in both a retrospective analysis of aprotinin use in clinical studies [2] and in the study reported by Furmin and colleagues from Columbia [3]. Furmin and colleagues, using their recent
This article has been cited by other articles:
![]() |
A. P. Furnary, Y. Wu, L. F. Hiratzka, G. L. Grunkemeier, and U. S. Page 3rd Aprotinin Does Not Increase the Risk of Renal Failure in Cardiac Surgery Patients Circulation, September 11, 2007; 116(11_suppl): I-127 - I-133. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |